May 30 (Reuters) - Lexaria Bioscience Corp LXX.CD :
* Lexaria Bioscience - co's 50 percent owned JV unit Ambarii trade corporation has entered into a LOI with naturally Splendid Enterprises Ltd
* Lexaria Bioscience - LOI for production, sale, distribution of Ambarii's proprietary sublingual full spectrum hemp cbd tablets in Japan and South Korea
* Lexaria Bioscience Corp - in addition to revenue generated from product sales, Ambarii will also receive a royalty on all sales
* Lexaria Bioscience-under terms, JV unit to manufacture, supply Ambarii CBD tablets to naturally splendid for exclusive distribution in Japan, South Korea
* Lexaria Bioscience- JV unit expects Japan and South Korea markets to contribute to "meaningful revenue growth" in 2017 and 2018 Source text for Eikon: ID:nMKWQlc86a Further company coverage: LXX.CD